Evidence map›Paper›PMID 25411580›Full record

ArticleChemistry Central journal2014

Characterization of the Vitrocell® 24/48 in vitro aerosol exposure system using mainstream cigarette smoke.

Shoaib Majeed, Stefan Frentzel, Sandra Wagner, Diana Kuehn, Patrice Leroy, Philippe A Guy, Arno Knorr, Julia Hoeng, Manuel C Peitsch

Open access · goldAbstract read
In one paragraph

Article in Chemistry Central journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Systems toxicology meta-analysis ofToxicology research · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Shoaib MajeedPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Stefan FrentzelPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Sandra WagnerEurofins Umwelt West GmbH, Vorgebirgsstraße 20, D-50389 Wesseling, Germany.
Diana KuehnPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Patrice LeroyPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Philippe A GuyPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Arno KnorrPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Julia HoengPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Manuel C PeitschPhilip Morris Research and Development, Quai Jeanrenaud 5, 2000 Neuchâtel, Switzerland.
Philip Morris International (Switzerland) · CHEurofins (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOnly a few exposure systems are presently available that enable cigarette smoke exposure of living cells at the air-liquid interface, of which one of the most versatile is the Vitrocell® system (Vitrocell® Systems GmbH). To assess its performance and optimize the exposure conditions, we characterized a Vitrocell® 24/48 system connected to a 30-port carousel smoking machine. The Vitrocell® 24/48 system allows for simultaneous exposure of 48 cell culture inserts using dilution airflow rates of 0-3.0 L/min and exposes six inserts per dilution. These flow rates represent cigarette smoke concentrations of 7-100%.

resultsBy characterizing the exposure inside the Vitrocell® 24/48, we verified that (I) the cigarette smoke aerosol distribution is uniform across all inserts, (II) the utility of Vitrocell® crystal quartz microbalances for determining the online deposition of particle mass on the inserts, and (III) the amount of particles deposited per surface area and the amounts of trapped carbonyls and nicotine were concentration dependent. At a fixed dilution airflow of 0.5 L/min, the results showed a coefficient of variation of 12.2% between inserts of the Vitrocell® 24/48 module, excluding variations caused by different runs. Although nicotine and carbonyl concentrations were linear over the tested dilution range, particle mass deposition increased nonlinearly. The observed effect on cell viability was well-correlated with increasing concentration of cigarette smoke.

conclusionsOverall, the obtained results highlight the suitability of the Vitrocell® 24/48 system to assess the effect of cigarette smoke on cells under air-liquid interface exposure conditions, which is closely related to the conditions occurring in human airways.

Indexed as

Air–liquid interfaceCarbonylCigarette smokeIn vitro exposure systemNicotineVitrocell®

Identifiers

PMID25411580
PMCPMC4236458
OpenAlexW2145742654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.